3176 results for «358»
3176 results
Advances in STEMI and Stable CAD
22 Sep 2023 – From AICT-AsiaPCR 2023
Explore cutting-edge insights into STEMI and Stable CAD through these presentations: delve into the intricate details of characterizing culprit coronary lesions in STEMI patients using OCT, uncover the short- and long-term outcomes for Asian STEMI patients following primary PCI and gain a comprehensive understanding of the...
Learning - Reimagining STEMI network
21 Sep 2023 – From AICT-AsiaPCR 2023
Consult this session to discover the profound impact of initiatives like Stent Saves a Life on patient care, to learn how artificial intelligence is transforming acute myocardial infarction management and to explore the role of pharmaco-invasive strategies and multi-vessel PCI in treating STEMI patients.
NSTEMI: lessons from real cases
21 Sep 2023 – From AICT-AsiaPCR 2023
Explore real-world cases in this NSTEMI session where experts discuss their experiences in managing challenging scenarios: learn about novel techniques to handle RCA perforations, restore torqued and kinked catheters, and more!
Navigating challenges in left main lesions
22 Sep 2023 – From AICT-AsiaPCR 2023
Dive into the world of left main coronary artery issues through these presentations, and discover how they tackle challenging scenarios, from cathlab nightmares and syncope management to complex left main bifurcation procedures and primary angioplasty in cardiogenic shock patient with prior angioplasty history.
Challenges in calcified lesions
21 Sep 2023 – From AICT-AsiaPCR 2023
Explore a variety of challenging cases in this session, from the perplexing uncrossable STEMI to the specialized "Blocked" balloon anchoring technique, the unique challenges of calcified lesions in elderly patients to the debulking of a calcified nodule within the left circumflex ostium through the stent strut,...
Strategies for unexpected stable CAD complications
22 Sep 2023 – From AICT-AsiaPCR 2023
Join us for this session as experts recount their experiences in successfully managing unexpected complications. Learn about a remarkable bailout of iatrogenic dissection in the right coronary artery, the challenges of severe catheter kinking and entrapment during transradial coronary angiography, and much more!
TAVI Insights: Addressing challenges and complex cases
21 Sep 2023 – From AICT-AsiaPCR 2023
In this session, explore the complexities of TAVR complications and learn about unique cases, including TAVI in patients with bicuspid aortic valves, coarctation of the aorta, and small annuli.
Innovations in TAVI and mitral interventions
22 Sep 2023 – From AICT-AsiaPCR 2023
Discover the latest advancements in TAVI and mitral interventions in this session: discover strategies for managing non-operable cases involving triple vessel disease and severe mitral regurgitation, along with insights into tackling recurrent heart failure in patients with coronary artery and valvular heart disease, delve into the...
Miscellaneaous - Exploring diverse topics
21 Sep 2023 – From AICT-AsiaPCR 2023
Dive into a variety of topics in this session, featuring discussions on catheter-directed thrombolysis and venous stenting for acute deep venous thrombosis, unconventional causes of positive treadmill tests, innovative IVUS angioplasty with stem cell UC-MSC in chronic limb-threatening ischemia, and the treatment of aortic arch aneurysms...
Contrast-less PCI
22 Sep 2023 – From AICT-AsiaPCR 2023
Discover various techniques for minimizing contrast usage during PCI procedures in this session, and learn about precautionary measures to prevent contrast-induced nephropathy, procedural steps for limiting contrast in complex PCI, as well as the valuable role of OCT imaging in low-contrast complex PCI decision-making and optimization.
Unconventional coronary interventions
21 Sep 2023 – From AICT-AsiaPCR 2023
Join us in this session where our experts speakers delve into their experiences with unexpected diagnostic challenges and share innovative strategies to tackle unique cases, such as subacute stent thrombosis, flow-limiting moderate stenosis with vulnerable plaque, PCI in Takayasu arteritis, and more!
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk
07 Nov 2021
Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...
Author
Author
World Heart Day 2023: Reducing the burden of cardiovascular disease globally: beyond stents and balloons!
29 Sep 2023
Global burden of Cardiovascular Disease
Cardiovascular disease (CVD) remains the lead cause of mortality for men and women globally. Our world population in 2023 is 8 billion! Of these, around 620 million people are living with heart and circulatory diseases across the world. Each year around 60...
Author
The Lancet Commission to reduce global burden of cardiovascular disease in women by 2030
29 Aug 2021
Vijay Kunadian summarizes the key points of the LBT session of the ESC congress 2021 held on Sunday, 29 August focusing on the Lancet Commission to reduce the global burden of heart disease in women by 2030.
Author
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions
08 Jan 2025
In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.
Author
